BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806XAB8. A total of 36 filers reported holding BRIDGEBIO PHARMA INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,408,804 | +62.1% | 16,880,000 | +31.1% | 0.00% | 0.0% |
| Q2 2023 | $10,121,267 | +18.3% | 12,880,000 | +11.7% | 0.00% | – |
| Q1 2023 | $8,554,851 | -31.3% | 11,530,000 | -57.4% | 0.00% | – |
| Q4 2022 | $12,458,274 | +55.8% | 27,060,000 | +100.0% | 0.00% | -100.0% |
| Q3 2022 | $7,997,000 | +25.1% | 13,530,000 | +17.3% | 0.00% | – |
| Q2 2022 | $6,390,000 | -15.0% | 11,530,000 | -8.7% | 0.00% | – |
| Q1 2022 | $7,519,000 | -37.3% | 12,630,000 | -22.1% | 0.00% | -100.0% |
| Q4 2021 | $11,985,000 | -47.8% | 16,205,000 | -2.4% | 0.00% | 0.0% |
| Q3 2021 | $22,954,000 | -5.8% | 16,605,000 | +12.2% | 0.00% | 0.0% |
| Q2 2021 | $24,375,000 | +28.6% | 14,805,000 | +29.0% | 0.00% | 0.0% |
| Q1 2021 | $18,948,000 | – | 11,480,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 49,655,000 | $82,515,000 | 3.29% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 80,000,000 | $131,952,000 | 2.77% |
| Aequim Alternative Investments LP | 22,000,000 | $36,397,000 | 2.35% |
| WOLVERINE ASSET MANAGEMENT LLC | 66,696,000 | $110,306,000 | 0.93% |
| Polar Asset Management Partners Inc. | 50,000,000 | $82,872,000 | 0.82% |
| Castle Creek Arbitrage, LLC | 6,500,000 | $10,746,000 | 0.62% |
| Soleus Capital Management, L.P. | 1,950,000 | $3,216,000 | 0.58% |
| WESTWOOD HOLDINGS GROUP INC | 16,000,000 | $26,497,000 | 0.27% |
| Nicholas Investment Partners, LP | 2,100,000 | $3,464,000 | 0.24% |
| Magnetar Financial LLC | 14,500,000 | $24,028,000 | 0.23% |